Objective To evaluate the clinical efficacy and adverse effects of irinotecan(CPT-11) combined with 5-Fu/FA in treatment of advanced colorectal cancer.

• 目的评价CPT-11联合5-Fu/FA方案治疗晚期结直肠癌的临床疗效及毒副反应。